Biotechnology

Techseriesinsight > Blog > News > Biotechnology

February 9, 2026
PRNewswire
Biotechnology, News

Diamyd Medical receives Notice of Allowance for key retogatein US patent

Diamyd Medical today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent covering the intralymphatic administration of retogatein (rhGAD65)...

February 6, 2026
PRNewswire
Biotechnology, News

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas

An overseas subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. (Blue-Zone) announced an agreement to collaborate on full lifecycle technology to capture and recycle waste anaesthetic gases. By...

February 5, 2026
PRNewswire
Biotechnology, News

PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ in patients with recurrent epithelial...

February 5, 2026
PRNewswire
Biotechnology, News

Tanmiah Partners with PHYLA and RECYCLEE to Bolster Circular Economy and Food Security

Tanmiah Food Company (TADAWUL: 2281), one of the Kingdom’s leading vertically integrated poultry and food producers, today announced the signing of two strategic Memorandums of Understanding (MoUs) with SEQUENCIVE...

February 5, 2026
PRNewswire
Biotechnology, News

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

The pharmaceutical industry’s most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board. The Board, which brings together 14 senior executives across pharma,...

MEXC Confirms Strong Asset Backing in Hacken-Audited 2026

February 4, 2026
Business Wire
Biotechnology, News

Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026

A late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a...

February 4, 2026
PRNewswire
Biotechnology, News

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0, Upcoming Webinar Hosted by Xtalks

Assuring that a stable cell line originates from a single progenitor cell is a fundamental component of the development of protein, cellular and gene therapies. However, monoclonality assurance is often...

February 3, 2026
PRNewswire
Biotechnology, News

Sobi to Showcase Scientific advances and Commitment to the Haemophilia community at EAHAD 2026

Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced its participation at the 19th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), taking place 3-6...

February 2, 2026
PRNewswire
Biotechnology, News

Nexus Agriscience Subsidiary Terpene Belt Farms Selected for UCLA-Led

Nexus Agriscience (“Nexus”), a molecular farming company delivering plant-based solutions for flavor, fragrance, and functional ingredient markets, announced today that its subsidiary, Terpene Belt Farms, is participating as the industry...

January 30, 2026
Business Wire
Biotechnology, News

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the...